Fierce Health Technology January 13, 2020
Paige Minemyer

SAN FRANCISCO—Growing and enhancing clinical capabilities is a key investment for insurance giant Humana, said CEO Bruce Broussard.

Broussard, speaking on a panel at the J.P. Morgan Healthcare Conference in San Francisco on Monday, said that the insurance industry as a whole is expanding capabilities around keeping members healthy and out of the hospital.

This is evidenced by the mergers and acquisitions, including some big-ticket deals, that have cropped up of late, he said.

For instance, CVS’ acquisition of Aetna combines a large national health insurer with a massive pharmacy chain and healthcare provider, and UnitedHealth Group has invested heavily in scooping up provider services, Broussard said.

“It’s all wrapped around: ‘How do you slow down the disease progression?'” Broussard...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Insurance, Investments, Patient / Consumer, Payer, Provider, Trends
25 payers among Forbes' best employers for diversity
Humana Reports $741 Million Profit And Boosts Medicare Forecast
Humana withdraws 2025 earnings outlook on unsatisfactory MA rates
Claims operation AI company Alaffia Health raises $10M in series A round
Humana plans to leave some Medicare Advantage markets in 2025

Share This Article